Loading...
Last deposits
-
Line Séguy, Florian Daressy, Sophia Lahlil, Sophie Corvaisier, Vincent Dumontet, et al.. In vitro evaluation of NA1-115-7-loaded nanoemulsions, an MCL-1-specific inhibitor of natural origin, intended to treat B-cell lymphoproliferative disorders after oral administration. International Journal of Pharmaceutics, 2023, 630, pp.122433. ⟨10.1016/j.ijpharm.2022.122433⟩. ⟨hal-04127315⟩
-
-
-
Claudia Consales, Caterina Merla, Barbara Benassi, Tomás Garcia-Sanchez, Adeline Muscat, et al.. Biological effects of ultrashort electric pulses in a neuroblastoma cell line: the energy density role. International Journal of Radiation Biology, 2021, 98 (1), pp.109-121. ⟨10.1080/09553002.2022.1998704⟩. ⟨hal-03875108⟩
-
Camille Hauguel, Sarah Ducellier, Olivier Provot, Nada Ibrahim, Diana Lamaa, et al.. Design, synthesis and biological evaluation of quinoline-2-carbonitrile-based hydroxamic acids as dual tubulin polymerization and histone deacetylases inhibitors. European Journal of Medicinal Chemistry, 2022, 240, pp.114573. ⟨10.1016/j.ejmech.2022.114573⟩. ⟨hal-03752715⟩
-
-
Vlada Zakharova, Mikhail Magnitov, Laurence del Maestro, Sergey Ulianov, Alexandros Glentis, et al.. SETDB1 fuels the lung cancer phenotype by modulating epigenome, 3D genome organization and chromatin mechanical properties. Nucleic Acids Research, 2022, 50 (8), pp.4389-4413. ⟨10.1093/nar/gkac234⟩. ⟨hal-03781895⟩
-
-
-
Laura Caramazza, Annalisa de Angelis, Zain Haider, Maxim Zhadobov, Franck Andre, et al.. A microdosimetric study at the cellular and intracellular level using a 3D realistic cell model. 51st European Microwave Conference (EuMC), Apr 2022, London, United Kingdom. ⟨10.23919/EuMC50147.2022.9784171⟩. ⟨hal-03771481⟩
Fulltext
